Nomogram predicting overall and cancer specific prognosis for poorly differentiated lung adenocarcinoma after resection based on SEER cohort analysis

被引:0
作者
Song, Weijian [1 ]
Shi, Jianwei [1 ]
Zhou, Boxuan [1 ]
Meng, Xiangzhi [1 ]
Liang, Mei [1 ]
Gao, Yushun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Dept Thorac Surg, Nanli 17, Beijing 100021, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
国家重点研发计划;
关键词
Poorly differentiated lung adenocarcinoma (PDLA); SEER; Nomogram; Overall survival; Cancer-specific survival; INVASIVE PULMONARY ADENOCARCINOMA; INTERNATIONAL ASSOCIATION; GRADING SYSTEM; SURVIVAL; VALIDATION; GENDER; AGE;
D O I
10.1038/s41598-024-73486-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The prognosis of poorly differentiated lung adenocarcinoma (PDLA) is determined by many clinicopathological factors. The aim of this study is identifying prognostic factors and developing reliable nomogram to predict the overall survival (OS) and cancer-specific survival (CSS) in patients with PDLA. Patient data from the Surveillance, Epidemiology and End Results (SEER) database was collected and analyzed. The SEER database was used to screen 1059 eligible patients as the study cohort. The whole cohort was randomly divided into a training cohort (n = 530) and a test cohort (n = 529). Cox proportional hazards analysis was used to identify variables and construct a nomogram based on the training cohort. C-index and calibration curves were performed to evaluate the performance of the model in the training cohort and test cohorts. For patients with PDLA, age at diagnosis, gender, tumor size were independent prognostic factors both for overall survival (OS) and cancer-specific survival (CSS), while race and number of nodes were specifically related to OS. The calibration curves presented excellent consistency between the actual and nomogram-predict survival probabilities in the training and test cohorts. The C-index values of the nomogram were 0.700 and 0.730 for OS and CSS, respectively. The novel nomogram provides new insights of the risk of each prognostic factor and can assist doctors in predicting the 1-year, 3-year and 5-year OS and CSS in patients with PDLA.
引用
收藏
页数:12
相关论文
共 47 条
  • [1] Nomograms in oncology: more than meets the eye
    Balachandran, Vinod P.
    Gonen, Mithat
    Smith, J. Joshua
    DeMatteo, Ronald P.
    [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
  • [2] Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab
    Bureau, Mathilde
    Chatellier, Thierry
    Perennec, Tanguy
    Goronflot, Thomas
    Greilsamer, Charlotte
    Chene, Anne-Laure
    Affi, Raafet
    Frampas, Eric
    Bennouna, Jaafar
    Pons-Tostivint, Elvire
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1747 - 1756
  • [3] Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
    Dai, Chenyang
    Shen, Jianfei
    Ren, Yijiu
    Zhong, Shengyi
    Zheng, Hui
    He, Jiaxi
    Xie, Dong
    Fei, Ke
    Liang, Wenhua
    Jiang, Gening
    Yang, Ping
    Petersen, Rene Horsleben
    Ng, Calvin S. H.
    Liu, Chia-Chuan
    Rocco, Gaetano
    Brunelli, Alessandro
    Shen, Yaxing
    Chen, Chang
    He, Jianxing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3175 - +
  • [4] Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations
    Deng, Chaoqiang
    Zheng, Qiang
    Zhang, Yang
    Jin, Yan
    Shen, Xuxia
    Nie, Xiao
    Fu, Fangqiu
    Ma, Xiangyi
    Ma, Zelin
    Wen, Zhexu
    Wang, Shengping
    Li, Yuan
    Chen, Haiquan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : 1684 - 1693
  • [5] Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases
    Fassi, Elena
    Mandruzzato, Marcella
    Zamparini, Manuel
    Bianchi, Susanna
    Petrelli, Fausto
    Baggi, Alice
    Alberti, Andrea
    Grisanti, Salvatore
    Berruti, Alfredo
    [J]. LUNG CANCER, 2023, 179
  • [6] Factors Affecting Physicians' Intentions to Communicate Personalized Prognostic Information to Cancer Patients at the End of Life: An Experimental Vignette Study
    Han, Paul K. J.
    Dieckmann, Nathan F.
    Holt, Christina
    Gutheil, Caitlin
    Peters, Ellen
    [J]. MEDICAL DECISION MAKING, 2016, 36 (06) : 703 - 713
  • [7] Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer
    Hanagiri, Takeshi
    Sugio, Kenji
    Uramoto, Hidetaka
    So, Tetsuya
    Ichiki, Yoshinobu
    Sugaya, Masakazu
    Ono, Kenji
    Yasuda, Manabu
    Nozoe, Tadahiro
    Yasumoto, Kosei
    [J]. SURGERY TODAY, 2007, 37 (07) : 546 - 551
  • [8] Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study
    Hou, Likun
    Wang, Tingting
    Chen, Donglai
    She, Yunlang
    Deng, Jiajun
    Yang, Minglei
    Zhang, Yu
    Zhao, Mengmeng
    Zhong, Yifan
    Ma, Minjie
    Zhao, Guofang
    Chen, Yongbing
    Xie, Dong
    Zhu, Yuming
    Chen, Qiankun
    Wu, Chunyan
    Chen, Chang
    [J]. MODERN PATHOLOGY, 2022, 35 (06) : 749 - 756
  • [9] The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma
    Hou, Yucheng
    Song, Weijian
    Chen, Mingzhi
    Zhang, Jianfeng
    Luo, Qingquan
    Um, Sang-Won
    Facchinetti, Francesco
    Bongiolatti, Stefano
    Zhou, Qianjun
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (01) : 64 - +
  • [10] How to build and interpret a nomogram for cancer prognosis
    Iasonos, Alexia
    Schrag, Deborah
    Raj, Ganesh V.
    Panageas, Katherine S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1364 - 1370